4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0000905148-24-002302
EVP, Global Head RA & Quality sold 963 shares at an average $6.63 ($6,384)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Henrich Jill EVP, Global Head RA & Quality | 2024-08-16 | Sale | −831 | $6.63 | $5,509 | 20,510 | D: show line 1 in the form |
| Henrich Jill EVP, Global Head RA & Quality | 2024-08-16 | Sale | −132 | $6.63 | $875 | 20,378 | D: show line 2 in the form |
| Open-market sales · 963 sh · avg $6.63 · $6,384 | |||||||
Loading xslF345X05/form4.xml…